Order Article Reprints

Witte HM, Bonorden B, Riecke A, Biersack H, Steinestel K, Merz H, Feller AC, Bernard V, Fetscher S, von Bubnoff N, et al. The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation. Cancers. 2020; 12(4):921. https://doi.org/10.3390/cancers12040921

Witte, Hanno M., Bastian Bonorden, Armin Riecke, Harald Biersack, Konrad Steinestel, Hartmut Merz, Alfred C. Feller, Veronica Bernard, Sebastian Fetscher, Nikolas von Bubnoff, and et al. 2020. "The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation" Cancers 12, no. 4: 921. https://doi.org/10.3390/cancers12040921

Witte, H. M., Bonorden, B., Riecke, A., Biersack, H., Steinestel, K., Merz, H., Feller, A. C., Bernard, V., Fetscher, S., von Bubnoff, N., & Gebauer, N. (2020). The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation. Cancers, 12(4), 921. https://doi.org/10.3390/cancers12040921